Joslin Diabetes Center Signs Agreement With China Horae Capital Management Group
BOSTON, Sept. 18, 2017 /PRNewswire-USNewswire/ -- Joslin Diabetes Center, the world's preeminent diabetes care and research center, today announced it has signed an agreement with China Horae Capital Management Group Co., Ltd. to advise the Horae Nanjing Diabetes Center project currently in development in the city of Nanjing, China. Initial work for Joslin experts will focus on providing guidance on the scope of the new center and training key leadership. Following that, Joslin experts will help develop the Center's inpatient and outpatient care models, create the educational curriculum for patients and educate the center's caregivers.
"We are excited to partner with Joslin Diabetes Center to bring Joslin's world-renowned best practices in diabetes prevention, treatment and management to the people of Nanjing. This is just the beginning; we hope to eventually spread what we learn from the experts at Joslin to our other locations throughout China," said Yuet Chai, Chairman, China Horae Capital Management Group Co., Ltd.
"Joslin Diabetes Center is thrilled to be partnering with China Horae Capital Management Group Co., Ltd. on this project," said Peter S. Amenta, M.D., Ph.D., President and CEO of Joslin. "China is experiencing a dramatic increase in the number of people with diabetes. We believe the collaboration between Joslin and Horae will help curb the complications stemming from diabetes and will make a huge impact on the quality of life for the people of Nanjing."
About Joslin Diabetes Center
Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S. For more information, visit www.joslin.org or follow @joslindiabetes
About China Horae Capital Management Group Co., Ltd.
China Horae Capital Management Group Co., Ltd. aims to build a full range of leading international, high-tech health industry clusters with innovative business models and advanced management concepts. These clusters built with multiple perspectives including research, education, technology transfer, industrial incubation, medical services and financial capital, will form a comprehensive industrial ecological chain, and serve to boost China's health industry to achieve leapfrog development through the combination of cutting-edge biotechnology and industrial capital.
View original content with multimedia:http://www.prnewswire.com/news-releases/joslin-diabetes-center-signs-agreement-with-china-horae-capital-management-group-co-ltd-300521217.html
SOURCE Joslin Diabetes Center
